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Objective To study the association between wheezy
symptoms in young children and the presence of bacteria
in the airways.
Design Birth cohort study.
Setting Clinical research unit in Copenhagen.
Participants Children of asthmatic mothers, from age
4 weeks to 3 years, with planned visits and acute
admissions to the research clinic.
Main outcome measure Frequency of bacteria and virus
carriage in airway aspirates during wheezy episodes and
at planned visits without respiratory symptoms.
Results 984 samples (361 children) were analysed for
bacteria, 844 (299 children) for viruses, and 696 (277
children) for both viruses and bacteria. Wheezy episodes
were associated with both bacterial infection (odds ratio
2.9, 95% confidence interval 1.9 to 4.3; P<0.001) and
virusinfection(2.8,1.7to4.4;P<0.001).Theassociations
of bacteria and viruses were independent of each other.
Conclusion Acute wheezy episodes in young children
were significantly associated with bacterial infections
similar to but independent of the association with virus
infections.
INTRODUCTION
Recurrent wheezy episodes in young children are the
major reason for use of paediatric healthcare
resources
1 and represent an important unmet need
for improved treatment strategies.
2 Virus infections
have been repeatedly and consistently associated with
wheezy episodes,




the United States found that antibiotics were among
the most commonly prescribed drugs for wheezy epi-
sodes in this population.
10 Yet no studies have sug-
gested that bacterial infections are associated with
wheezyepisodesinyoungchildrenandnorandomised
controlled trials have reported the clinical efficacy of
antibioticsforsuchepisodes.Currentguidelinesforthe
treatment of wheezy episodes in preschool children
recommend that antibiotics should not be given
routinely.
6
In this study we determined if common pathogenic
bacteriawereassociatedwithacutewheezyepisodesin
childrenandwhetheranyassociationwasindependent
of virus infection. The children were prospectively
examined for common airway pathogenic bacteria
andvirusesfromage4weeksto3yearsduringwheezy
episodes and outside of such episodes as a part of the
Copenhagen Prospective Study on Asthma in Child-
hood. To validate the pathogens detected, we also
investigated the association of infections with clinical
pneumonia.
METHODS
The Copenhagen Prospective Study on Asthma in
Childhood is a clinical study following a birth cohort
of 411 children born in the Copenhagen area.
11-13
Infants of mothers with a history of doctor diagnosed
asthma were included at four weeks of age between
August 1998 and December 2001. Children were
excluded if born before 36 weeks of gestation or if
they had a history of mechanical ventilation, congeni-
tal disease, or respiratory tract symptoms.
Oral and written informed consent was obtained
from both parents of participating children. History
wascollectedonlineduringvisitstothestudy’sclinical
research unit and entered into a database. Measure-
ments were entered into the database and double
checked against source data, after which the database
was locked.
The Copenhagen Prospective Study on Asthma in
Childhood is an ongoing cohort study, but this report
isbasedonanestedstudyduringthefirstthreeyearsof
life when children were sampled for airway bacteria
and viruses during episodes of acute respiratory tract
symptoms and at planned visits without lower respira-
tory tract symptoms.
Acute respiratory tract symptoms
We defined wheezy episodes from daily symptom dia-
riesasthreeconsecutivedaysofwheeze,atwhichpoint
parents were asked to bring their child to the research
unit.
11-13 Wheeze was recorded as a composite dicho-
tomised score (yes or no) together with use of rescue
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recordsymptoms,withemphasisonthelowerairways.
Wheeze was translated to the parents as any symptom
that severely affected their child’s breathing, such as
noisybreathing(wheezeorwhistlingsounds),shortness
ofbreath,orpersistenttroublesomecoughaffectingthe
sleep or activity of the child. The parents received a
book on asthma-like symptoms and treatment in
young children (www.copsac.dk/content/parents-read
ing). The doctors at the research clinic collected and
reviewed the diary cards at the half yearly visits.
Objective wheeze was diagnosed by a doctor at the
research clinic and defined as audible wheeze, pro-
longed expiration, or ronchi by auscultation. Clinical
pneumonia was diagnosed from tachypnoea, fever,
andauscultationbutbeforecultureshadbeenobtained
and independent of radiography.
Study design
The children visited the research clinic every six
monthsaswellasforacuterespiratorytractsymptoms,
including wheezy episodes for three days (as prede-
fined from diaries), clinical pneumonia, or other epi-
sodes of respiratory distress. This algorithm
encouraged the parents to bring their child to the
research clinic instead of the family doctor for such
acute respiratory symptoms. At each acute visit up to
age 3 years the children were examined by doctors
trained in paediatrics and clinical research for diagno-
sis and treatment of any acute respiratory symptom
episodeinaccordancewithpredefinedstandardproce-
dures. The children received a standardised physical
examination, including auscultation of the lungs.
11-13
Hypopharyngeal aspirates were obtained for routine
bacterial cultures and nasopharyngeal aspirates for
virus identification.
Aspirates were also taken from the same children at
the scheduled one year visit if they lacked lower
respiratory tract symptoms or only had fever and
upper respiratory tract symptoms.
Bacterial cultures
Adoctorattheclinicaspiratedthehypopharynxunder
aseptic conditions with a soft suction catheter passed
through the nose. Aspiration was done intermittently
assuring no suction was applied during retraction
through the oropharynx and nasopharynx. The cathe-
ter was flushed with 1 ml of saline into a vessel to flush
outsecretionsfromthetube.Samplesweretransported
at room temperature to the microbiology laboratories
withintwohoursofcollection.Streptococcuspneumoniae,
Haemophilus influenzae, Moraxella catarrhalis, Streptococ-
cus pyogenes, and Staphylococcus aureus were identified
according to standard procedures.
14
Positive bacterial cultures obtained during wheezy
episodes were termed “infection” and positive bacter-
ialculturesobtainedwithoutwheezeas“colonisation.”
We excluded samples from children who had taken
antibiotics within the past week.
15
Detection of viruses and atypical bacteria
A doctor at the clinic aspirated the upper rhinophar-
ynx under aseptic conditions with a soft suction cathe-
ter. We used polymerase chain reaction of
nasopharyngeal samples to detect picornaviruses
(mostly rhinoviruses); respiratory syncytial virus; cor-
onaviruses229EandOC43;parainfluenzaviruses1-3;
influenza viruses AH1, AH3, and B; human meta-
pneumoviruses; adenoviruses and bocavirus; and the
two atypical bacteria Mycoplasma pneumoniae and Chla-
mydophila pneumoniae, as described.
16 Bocavirus was
detectedon2μlrandomprimedcDNAbypolymerase
chain reaction primers HBOV 01.2 TAT-GGC-CAA-
GGC-AAT-CGT-CCA-AG and HBOV 02.2 GCC-
GCG-TGA-ACA-TGA-GAA-ACA-GA with the
cycling conditions 94°C, 56°C, and 72°C each for
20secondsfor35cycles.Positivecontrolwascomplete
coding genome of bocavirus plasmid DNA.
Viruses detected during wheezy episodes were
defined as infection and viruses identified from chil-




ing for planned visits and those for acute wheezy
episodes. A proportion of children had missing data
on samples at the one year visit, primarily because
the protocol was started after the beginning of the
cohort study. We therefore considered these missing
data as randomly distributed and did not compare the
characteristics of children with or without samples at
oneyear.Asvirusesarewell knowntriggersof wheeze
and a potential confounder of the association between
bacteria and wheeze, we controlled for viruses in bac-
teria samples and bacteria in virus samples by includ-
ing both in the multivariate analyses.
Statistical analyses
We used logistic regression with generalised estimat-
ing equation to assess differences in the presence of
bacteria and viruses in samples from children with
wheeze and those without wheeze. In our modelling
weassumedaworkingindependencecorrelationstruc-
ture,not anunstructuredcorrelationstructure.Wedid
not use any statistical criterion for the selection of the
“best”correlationstructure,butwecouldmeasurethat
in our data, the generalised estimating equation esti-
mates eventually only scarcely depended on the cor-
rect choice of the correlation structure, as tested using
different structures (independent, exchangeable, and
first order autoregressive).
Analyses were adjusted for age at examination and
for bacteria and viruses present in the same sample in
the respective analyses of independent effects. P
values, 95% confidence intervals, and interaction
between bacteria and viruses were estimated by a
robust Wald test based on the independence working
generalised estimating equation approach taking
repeated measurements of each child into account.
We used a sandwich estimator for the estimation of
RESEARCH
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analysesweredoneusingtheRstatisticalsoftware(ver-
sion 2.7.0) including the package geepack.
RESULTS
Thebirthcohortstudyincluded411children.Theclin-
ical follow-up rate of the cohort was 95% at age 1, 90%
at age 2, and 85% at age 3.
Table 1showsthestudybaseselectionofsamplesof
cases analysedforbacteria andviruses duringthe non-
wheezy periods, cases of clinical pneumonia, and
wheezy episodes.
A total of 984 samples (361 children) were analysed
for bacteria, 844 (299 children) for viruses, and 696
(277 children) for both viruses and bacteria. Bacterial
cultures were obtained from 705 respiratory episodes;
74 samples were excluded from the group of cases
because antibiotics had been taken within the past
week, 87 because the sample was taken for an episode
of less than three days or symptoms were judged to be
caused by infection in the upper airways (including
pseudocroup), 144 represented episodes with signs of
clinical pneumonia, and the remaining 400 were col-
lected during wheezy episodes.
Viruses were analysed in samples from 757 respira-
tory episodes; 95 were excluded from the group of
cases because the sample was taken for an episode of
less than three days or symptoms were judged to be
caused by infection in the upper airways (including




of wheezy episodes with airway sampling per child.
Most of the children had three or fewer wheezy epi-
sodes. Web extra figure 2 shows the distribution of
samples taken during wheezy episodes according to
age group. Most of the samples were from children
aged 6-18 months. The type of bacteria cultured from
samples during wheezy episodes was noticeably asso-
ciated with age (see web extra figure 3). Colonisation
shiftedfromamajorityofSaureusinthefirstmonthsof
lifetoSpneumoniae,Hinfluenzae,andMcatarrhalisbeing
the most commonly detected bacteria later.
Control samples from children without wheeze or
other respiratory symptoms in the preceding week
consisted of 279 samples analysed for bacteria and 87
analysed for viruses. Eighty one of these control sam-
ples were obtained from children with symptoms of a
cold (n=47), otitis media (n=24), or fever (n=10).
Table 2 shows the distribution of bacteria and viruses
during the non-wheezy periods, cases of clinical pneu-
monia, and wheezy episodes.
Bacterial infection and acute wheezy episodes
Wheezy episodes were significantly associated with H
influenzae, M catarrhalis, and S pneumoniae overall(odds
ratio 2.9, 95% confidence interval 1.9 to 4.3, P<0.001;
figure and table 3). The association was significant for
H influenzae and M catarrhalis individually but not for S
pneumoniae.
Restricting the analysis to episodes with objective
wheeze at the clinical examination (n=142) did not
materially change the estimated association between
bacterial infection and wheeze (2.4, 1.3 to 4.2;
P=0.005), neither did restriction of the analysis to spe-
cimens with ciliated columnar epithelium from 134
non-wheezy episodes and 303 wheezy episodes (2.4,
1.3 to 4.4). Also, the association remained significant
and with similar effect estimates when virus infection
wasincludedasacovariateinthemorerestrictedpopu-
lationwithbothdata(2.5,1.0to6.2;P=0.049)andwith
no significant interactions (P=0.32).Restricting to chil-
dren with four episodes or fewer increased the esti-
mates.
Clinical pneumonia was strongly associated with H
influenzae, M catarrhalis, and S pneumoniae (5.6, 2.4 to
13.0; P<0.001). Restricting the analysis of association
betweenclinicalpneumoniaandbacteriatospecimens
with ciliated columnar epithelium (134 non-wheezy
and114clinicalpneumonia)didnotmateriallychange
the estimated association (5.9, 2.1 to 17.0; P<0.001).
Also, the association remained significant when virus
infection was included as a covariate in the restricted
populationwithbothdata(2.9,1.2to7.3;P=0.02).The
association was significant for S pneumoniae, H influen-
zae, and M catarrhalis individually, whereas S aureus
showed no significant associations with either clinical
pneumonia or wheezy episodes.
Viral infection and acute respiratory episodes
Wheezy episodes were significantly associated with
viral infection (at least one of picornavirus, respiratory
syncytial virus, coronavirus, parainfluenzavirus, influ-
enza virus, human metapneumoviruses, adenovirus,
or bocavirus) (odds ratio 2.8, 95% confidence interval
1.7 to 4.4, P<0.001; table 3). When the analysis was
restrictedtoepisodeswithobjectivewheezeattheclin-
ical examination (n=180), a similar association was
seen between viral infection and wheeze (3.7, 2.1 to
6.6; P<0.001). The association was unaffected by bac-
teria as covariate(2.8, 1.6 to 4.9; P<0.001)and with no
significant interactions (P=0.37). Clinical pneumonia
was significantly associated with infection with any of
the eight types of virus (4.2, 2.4 to 7.4; P<0.001). The
Table 1 |Study base selection of samples from young children with clinical pneumonia,




Total 844 from 299 children 984 from 361 children
Excluded:
Antibiotics in past week — 74




Clinical pneumonia in past week 181 144
Wheezy episode (≥3 consecutive days) 481 400
Controls:
Without wheeze in past week 87 279
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 6association remained significant when bacteria were
included as covariate (4.5, 2.3 to 8.7; P<0.001).
Atypical bacterial species and acute respiratory episodes
Atypical bacteria were detected in 2% of samples from
children with wheezy episodes, 1% from children with




Acute wheezy episodes in children up to age 3 years
were significantly associated with bacterial infection.
Viral infection was also associated with wheezy epi-
sodes, with similar but independent effects. Both bac-
teria and viruses were also associated with clinical
pneumonia.
Strength and weaknesses of the study
A major strength of this study was the clinical surveil-
lanceofabirthcohortattendingtheresearchclinicand
not other healthcare facilities. Clinical diagnosis and
sampling were done at the clinic by experienced
studydoctorsinaccordancewithstandardprocedures.
This approach reduced the risk of misclassification of
illness and variation in sampling quality. The children
werebroughttotheclinicfordiagnosisofacuterespira-
tory episodes, including wheeze and clinical pneumo-
nia. Although the differentiation between the clinical
presentations of wheeze and clinical pneumonia may
be contested, the children were assessed by the same
doctors in accordance with standard operating proce-
dures; the sampling for viruses and bacteria was inde-
pendentofsuchadistinction,andtheclinicaldiagnosis
was independent of microbiological outcomes.
Anotherstrengthofthisstudywasthe monitoringof
wheezy symptoms in daily diaries. This assured that
wheezy episodes with a predefined burden of symp-
toms led to clinic visits. Results were validated by
restricted analysis of episodes with objective wheezing
verified by auscultation by the attending doctor.
That all mothers had a history of asthma may have
improved the validity of their observations of wheez-
ing in their children.
The longitudinal study design allowed for wheezy
children to act as their own controls when without
wheeze.
This is the first prospective clinical cohort study to
investigate both bacterial and viral infections simulta-
neously in wheezy episodes in children using standard
bacterial cultures and sensitive molecular methods for
virus detection. Bacterial cultures from hypopharyn-
geal aspirates were routinely collected as part of this
evaluation,withepitheliumfromthelowerrespiratory
tract present in most samples. It is a strength that bac-
teria and viruses were identified both in wheezy epi-
sodes and in cases of clinical pneumonia. The doctors
at the clinic distinguished clinical pneumonia from
wheezyepisodesonthebasisofthepresenceoftachyp-
noea, fever, and crepitation on auscultation without
wheeze in accordance with standard operating proce-
dures.Thisistraditionalclinical semanticsbuildingon
scarce evidence, but we know of no better distinction.
These clinical entities may be difficult to separate in
clinical practice but the independent associations of
virusesandbacteriaweresimilarwhetherthepresenta-
tion was dominated by clinical signs of pneumonia or
by wheeze.
To avoid bias in the analysis we allowed children
with episodes of upper respiratory tract symptoms
and fever in the control group. We tested if bacteria
and viruses are associated with wheezy episodes and
therelevantcontrolgroupwasthereforechildrenwith-
outsuchsymptoms.Hadweexcludedchildrenwithall
symptoms from the control group we would have
inflated the risk while introducing a bias that might
have resulted in a difference between groups that was
due to association between microbes and such upper
respiratory tract symptoms or fever. The exclusion or
inclusion of upper airway symptoms from the control















































Association of viruses and bacteria with wheezy episodes in
young children
Table 2 |Distribution of bacteria and viruses during periods of no wheeze, signs of clinical
pneumonia, and wheezy episodes. Values are percentages (numbers) unless stated
otherwise
Variables No wheeze Clinical pneumonia Wheezy episodes
Median age of sampling (months) 12 15 14
Bacteria: n=279 n=144 n=400
Streptococcus pneumoniae 38 (105) 59 (85) 46 (185)
Haemophilus influenzae 26 (73) 47 (67) 44 (174)
Moraxella catarrhalis 29 (81) 52 (76) 50 (199)
Staphylococcus aureus 20 (57) 9 (13) 15 (61)
Streptococcus pyogenes <1 (2) <1 (1) 1 (4)
Percentage ciliated columnar epithelium 60 79 76
Viruses: n=87 n=181 n=481
Picornaviruses 22 (19) 27 (48) 29 (141)
Respiratory syncytial virus 9 (8) 30 (55) 17 (80)
Coronaviruses 10 (9) 12 (22) 13 (61)
Parainfluenza viruses 1 to 3 0 (0) 7 (13) 8 (39)
Influenza viruses 2 (2) 8 (14) 6 (31)
Bocavirus 1 (1) 6 (10) 8 (40)
Human metapneumoviruses 0 (0) 4 (7) 4 (18)
Adenoviruses 1 (1) <1 (1) 1 (5)
Any virus type 40 (35) 70 (127) 65 (315)
Multiple types 6 (5) 22 (40) 18 (85)
RESEARCH
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Prospective Study on Asthma in Childhood was simi-
lar to that reported in previous cohort studies,
17-19
although S aureus seemed slightly more common in
our cohort, which may have been due to the high rate
of breast feeding.
20
The anatomical origin of the bacteria cultured is
uncertain. Ciliated columnar epithelium arose from
the lower respiratory tract in 60% of samples from
1 year olds with no wheeze and 76% from episodes
with wheeze. Restricting analyses to specimens with
ciliated columnar epithelium did not, however, mate-
rially change the results.
A limitation of our findings was that the investiga-
tions were carried out in a high risk population. The
selection for maternal asthma and exclusion of prema-
ture babies limit the generalisability of the findings,
which need replication in population based studies.
It is a limitation of this and other studies on respira-
tory symptoms in young children, that symptoms are
reported second hand and with no available terminol-
ogy that communicates specific meaning in lay terms.
We put much emphasis on training and supervising
parents in the understanding of asthma related symp-
toms. Our definition of wheezy episodes (symptoms
severely affecting breathing, such as noisy breathing
(wheeze or whistling sounds); shortness of breath; or
persistent troublesome cough affecting sleep or activ-
ity) was validated by our previous reports on signifi-




icant association to be shown between bacteria and
wheezing symptoms adjusted for viruses but could
not definitively prove the causative role of bacteria.
This could only be done in a controlled randomised
trial of antibacterial treatment. Indeed, this is similar
totheroleofviruses,whichisonlyprovedtotheextent
of association.
Meaning of the study
To our knowledge this is the first prospective study
using good quality sampling and detection methods
to analyse the roles of both bacterial and viral infec-
tions during wheezy episodes and periods with no
wheeze within the same cohort of young children.
Viral infection is closely associated with acute
exacerbations of asthma.
45Viruses were identified in
65% of wheezy episodes in the children in this study
and in 40% of samples during periods without respira-
tory symptoms and with similar distribution among
types in wheezy and non-wheezy children. The simi-
larity in distribution of virus types in wheezy children
and asymptomatic children suggests that the type of
virus itself is not causally related to symptoms. Simi-
larly, bacteria were more commonly found in wheezy
episodesbutwithsimilardistributionwhencomparing
young children with and young children without
wheezy episodes.
A recent clinical trial showed telithromycin to be
effective in the treatment of acute exacerbations of
asthma in adults,
23 and clarithromycin alleviated the
symptom burden, reduced the risk of readmission for
respiratory syncytial virus related bronchiolitis,
24 and
reduced levels of inflammatory cytokines in children
with recurrent wheeze.
25 A study of long term therapy
(six weeks) with azithromycin in stable asthma also
showed significant clinical benefits.
26 It is unclear if
such benefits are related to an effect on atypical bac-
teria, general antibacterial effects, or anti-inflamma-
tory properties.
2327 Furthermore, adults with asthma
had an increased risk of severe pneumococcal
disease
28 as well as impaired innate immune responses
to bacterial lipopolysaccharide.
29 Whether these
observations are relevant to this study in children
requires further elucidation.
Our findings should not be confused with our pre-
vious observation of an association between colonisa-
tionoftheairwayswithpathogenicbacteriaat1month
of age and development of asthma years later.
13 The
current study reports an association between acute
wheezing symptoms and presence of bacteria at the
time of wheezing, a relation unrelated to the colonisa-
tion of neonates.
Clinicaltrialswithantibiotictherapywillberequired
to determine whether this increased detection of bac-
teria during wheezy episodes has clinical effects that
are amenable to modification by appropriate therapy.
If bacteria can be confirmed to be contributing to
wheezy episodes in young children, this may have an
important impact on treatment. This discovery may
also contribute to an understanding of the disappoint-
ing results from trials of anti-asthma therapies in
wheezing illness in early childhood.
2
Conclusion
We found a significant association between bacterial
infection of the airways and acute wheezy episodes in
young children. This association was independent of
Table 3 |Association between bacteria and viruses and wheezy episodes in children up to age 3 years
Wheezy episodes Bacteria P value Virus P value
Bacteria adjusted
for viruses P value
Overall 2.9 (1.9 to 4.3) <0.001 2.8 (1.7 to 4.4) <0.001 2.5 (1.0 to 6.2) 0.049
≤4 episodes 3.5 (2.0 to 6.3) <0.001 3.5 (2.0 to 6.0) <0.001 4.0 (1.4 to 11.6) 0.012
RESEARCH
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independently to the burden of wheezy symptoms.
The clinical relevance of bacteria for wheezy episodes
should be studied in randomised controlled trials of
antibiotic treatment in this setting.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Viral infections are associated with acute wheezy episodes in young children
WHAT THIS STUDY ADDS
Bacterial infections are significantly associated with acute wheezy episodes in young
children similar to but independent of the association with viral infections
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